Neutralizing activity to SARS‐CoV‐2 of convalescent and control plasma used in a randomized controlled trial

BACKGROUND: There are limited data on the neutralizing activity of convalescent plasma (CP) administered in randomized controlled trials (RCT) of COVID‐19 infection. STUDY DESIGN AND METHODS: As part of an RCT, CP was collected per FDA guidelines from individuals recovered from COVID‐19 infection. C...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Transfusion
Главные авторы: Freedenberg, Alex T., Pan, Chun‐Hao, Diehl, William E., Romeiser, Jamie L., Hwang, Ga‐Ram, Leiton, Cindy V., Muecksch, Frauke, Shroyer, Kenneth R., Bennett‐Guerrero, Elliott
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley & Sons, Inc. 2021
Предметы:
Brief Reports
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8014203/
https://ncbi.nlm.nih.gov/pubmed/33448402
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.16283
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы